Ramipril Drug Profile

What is Ramipril?

Ramipril is an angiotensin-converting enzyme (ACE) inhibitor used primarily to treat high blood pressure and heart failure. It belongs to a class of medications that help relax blood vessels and reduce the workload on the heart. Ramipril is also prescribed to reduce the risk of heart attack, stroke, and death in people at high cardiovascular risk.

Uses

Ramipril is FDA-approved and commonly prescribed for several cardiovascular conditions:

• Hypertension (high blood pressure): Helps lower blood pressure by relaxing blood vessels, reducing the risk of stroke and heart attack
• Heart failure: Improves heart function and symptoms in patients with reduced ejection fraction
• Cardiovascular risk reduction: Decreases the risk of heart attack, stroke, and cardiovascular death in high-risk patients
• Post-heart attack protection: Prescribed after myocardial infarction to prevent further cardiovascular events
• Diabetic nephropathy: Helps protect kidney function in diabetic patients with protein in their urine

How it works

Ramipril blocks the angiotensin-converting enzyme, which prevents the formation of angiotensin II, a hormone that causes blood vessels to constrict and promotes sodium retention. By inhibiting this enzyme, ramipril allows blood vessels to relax and widen, reducing blood pressure and decreasing the heart’s workload. This mechanism also helps reduce fluid retention and improves blood flow throughout the body.

Side effects

Common side effects include:

Submit Your Paper

• Dry cough (occurs in 10-15% of patients)
• Dizziness or lightheadedness
• Headache
• Fatigue or weakness
• Nausea
• Low blood pressure (hypotension)
• Elevated potassium levels
• Kidney function changes

Serious side effects requiring immediate medical attention:

• Angioedema (swelling of face, lips, tongue, or throat)
• Severe hypotension with fainting
• Kidney failure or significant decrease in kidney function
• Hyperkalemia (dangerously high potassium levels)
• Severe allergic reactions

Warnings and precautions

• Pregnancy: Ramipril is contraindicated during pregnancy (Category D) as it can cause fetal harm, including kidney problems and death
• Kidney disease: Use with caution in patients with kidney impairment; regular monitoring of kidney function and electrolytes is required
• Angioedema history: Patients with a history of angioedema should not use ACE inhibitors due to increased risk of recurrence
• Dehydration: Avoid use during illness causing dehydration, vomiting, or diarrhea, as this increases the risk of severe low blood pressure
• Surgery: May need to be temporarily discontinued before major surgery due to risk of excessive blood pressure lowering during anesthesia

Interactions

• Potassium supplements and salt substitutes: May cause dangerous elevations in blood potassium levels
• Diuretics: Can enhance blood pressure-lowering effects, potentially causing excessive hypotension
• NSAIDs (ibuprofen, naproxen): May reduce ramipril’s effectiveness and increase kidney damage risk
• Lithium: ACE inhibitors can increase lithium levels, leading to toxicity
• Aliskiren: Combination increases risk of kidney problems, low blood pressure, and high potassium
• ARBs (losartan, valsartan): Dual blockade increases risk of kidney dysfunction and hyperkalemia
• Diabetes medications: May enhance blood sugar-lowering effects, requiring dose adjustments
• Gold injections: Rare reports of severe reactions when combined with ACE inhibitors

Check interactions with the GMJ Interaction Checker

Dosage

Ramipril dosing varies based on the condition being treated and individual patient factors. For hypertension, the typical starting dose is 2.5 mg once daily, which may be increased to 5-10 mg daily based on blood pressure response. Heart failure treatment usually begins with 1.25-2.5 mg twice daily, gradually increased to a target dose of 5 mg twice daily as tolerated. For cardiovascular risk reduction, the typical dose is 2.5 mg once daily for one week, then increased to 5 mg once daily, and may be further increased to 10 mg daily. All dosage adjustments should be made under medical supervision, with regular monitoring of blood pressure, kidney function, and electrolytes. Patients with kidney impairment may require lower starting doses and more frequent monitoring.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).